Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.24 USD | +1.67% | -0.33% | -10.67% |
May. 06 | Bausch + Lomb Shares Rise After Morgan Stanley Upgrade | MT |
May. 06 | Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equalweight, Raises Price Target to $18 From $16 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.67% | 5.36B | |
-4.72% | 182B | |
+3.96% | 114B | |
-2.93% | 68.38B | |
+6.30% | 52.46B | |
+8.02% | 44.25B | |
+7.52% | 43.55B | |
+26.18% | 32.69B | |
+17.85% | 26.73B | |
+0.57% | 25.79B |
- Stock Market
- Equities
- BLCO Stock
- News Bausch + Lomb Corporation
- Bausch + Lomb Brief: Says Received FDA Approval for TENEO Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery